Phoenix Biotech Acquisition Corp. announced a private placement of non-convertible promissory note for gross proceeds of $1,500,000 on December 16, 2022. The transaction includes participation from Phoenix Biotech Sponsor, LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.9178 USD | -2.37% | -16.56% | -91.66% |
1st Jan change | Capi. | |
---|---|---|
-91.66% | 13.51M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- CERO Stock
- News CERo Therapeutics Holdings, Inc.
- Phoenix Biotech Acquisition Corp. announced that it expects to receive $1.5 million in funding